Search - tctmd.com

Displaying 281 - 300 of 545

Sort: Relevancy | Date

Charles E. Chambers, Radiation Safety Proponent and Passionate Mentor, Dies at 64

News Daily News

Charles E. Chambers, Radiation Safety Proponent and Passionate Mentor, Dies at 64

Yael L. Maxwell

June 12, 2019

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

News Daily News

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

May 09, 2019

In the Wake of Guidelines, Antibiotic Prophylaxis for Infective Endocarditis Declined for Moderate Risk Patients

News Daily News

In the Wake of Guidelines, Antibiotic Prophylaxis for Infective Endocarditis Declined for Moderate-Risk Patients

May 07, 2019

The Perils of Perusing: New Research Cautions Against Relying Solely on RCT Abstracts

News Daily News

The Perils of Perusing: New Research Cautions Against Relying Solely on RCT Abstracts

May 07, 2019

FDA Approves Lotus Edge, Ushering Third Device Into US Market

News Daily News

FDA Approves Lotus Edge, Ushering Third Device Into US Market

April 24, 2019

Disparities Seen in Uptake of DOACs for VTE

News Daily News

Disparities Seen in Uptake of DOACs for VTE

April 05, 2019

FDA Extends MitraClip Indication to Include Functional MR

News Daily News

FDA Extends MitraClip Indication to Include Functional MR

March 14, 2019

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

News Daily News

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

March 01, 2019

Rising Number of CV-Related Maternal Deaths Spurs Need for #CardioObstetrics

News Daily News

Rising Number of CV-Related Maternal Deaths Spurs Need for #CardioObstetrics

February 27, 2019

FDA Adds Boxed Warning About CV Risks to Gout Drug Febuxostat

News Daily News

FDA Adds Boxed Warning About CV Risks to Gout Drug Febuxostat

February 22, 2019

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

News Daily News

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

January 23, 2019

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

News Daily News

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

January 15, 2019

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Vote

News Daily News

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review

January 11, 2019

Irrational Exuberance or Evidence-Based Medicine: What Role for CT Angiography in Stable Chest Pain?

News Daily News

Irrational Exuberance or Evidence-Based Medicine: What Role for CT Angiography in Stable Chest Pain?

Michael O'Riordan

January 11, 2019

The Biggest News of 2018: TCTMD’s Top 10

News Daily News

The Biggest News of 2018: TCTMD’s Top 10

December 31, 2018

Need to Spin a Negative Trial? Consult the Playbook

News Daily News

Need to Spin a Negative Trial? Consult the Playbook

December 20, 2018

Barbershop Intervention for High BP Has Lasting Effects

News Daily News

Barbershop Intervention for High BP Has Lasting Effects

December 19, 2018

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

News Daily News

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

December 18, 2018

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

News Daily News

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

December 17, 2018

CTA an Effective Gatekeeper in Invasive Angiography Candidates With Suspected CAD

News Daily News

CTA an Effective Gatekeeper in Invasive Angiography Candidates With Suspected CAD

December 14, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.